Combined General Meeting of May 21, 2025 - Availability of preparatory documents

Company Information - EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers' and patients' needs globally, being a leading player in active pharmaceutical ingredients with approximately 200 products in its portfolio [5] - The company has strong research and development capabilities and operates six manufacturing sites located in Europe, ensuring high-quality API manufacturing to supply customers in over 80 countries [6] - EUROAPI is listed on Euronext Paris with ISIN: FR0014008VX5 and ticker: EAPI [6] General Meeting Details - Shareholders are invited to the Combined General Meeting on May 21, 2025, at 10:30 a.m. (CET) in Paris [1] - The notice of the meeting was published in the French official legal announcement publication on April 16, 2025, and in Actu-juridique.fr on April 28, 2025 [1] - Documents related to the General Meeting are available on the company's website under the "Annual General Meeting 2025" section [2] Shareholder Communication - Registered shareholders can request additional documents via email or at the company's registered office, with documentation sent by post or email depending on their preference [3] - Shareholders are encouraged to regularly check the company's website for the latest information regarding the Annual General Meeting, which will be broadcast live unless technical issues arise [4]